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Abstract
Purpose Globally planned surgical procedures have been deferred during the current COVID-19 pandemic. The study aimed to
report the outcomes of planned urgent and cancer cases during the current pandemic using a multi-disciplinary prioritisation
group.
Methods A prospective cohort study of patients having urgent or cancer surgery at a NHS Trust from 1st March to 30th April
2020 who had been prioritised by a multi-disciplinary COVID Surgery group. Rates of post-operative PCR positive and
suspected COVID-19 infections within 30 days, 30-day mortality and any death related to COVID-19 are reported.
Results Overall 597 patients underwent surgery with a median age of 65 years (interquartile range (IQR) 54–74 years). Of these,
86.1% (514/597) had a current cancer diagnosis. During the period, 60.8% (363/597) of patients had surgery at the NHS Trust
whilst 39.2% (234/597) had surgery at Independent Sector hospitals. The incidence of COVID-19 in the East Midlands was
193.7 per 100,000 population during the study period. In the 30 days following surgery, 1.3% (8/597) of patients tested positive
for COVID-19 with all cases at the NHS site. Overall 30-day mortality was 0.7% (4/597). Following a PCR positive COVID-19
diagnosis, mortality was 25.0% (2/8). Including both PCR positive and suspected cases, 3.0% (18/597) developed COVID-19
infection with 1.3% at the independent site compared to 4.1% at the NHS Trust (p=0.047).
Conclusions Rates of COVID-19 infection in the post-operative period were low especially in the Independent Sector site.
Mortality following a post-operative diagnosis of COVID-19 was high.
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Introduction
It is estimated over 28 million operations will be deferred
globally during the COVID-19 pandemic peak [1]. Our un-
derstanding of the consequences of developing acute respira-
tory syndrome coronavirus 2 (SARS-CoV-2) infection in the
post-operative period is not yet clear, with initial reports sug-
gesting mortality in excess of 20% in confirmed cases [2].
International and National guidance on the management of
patients in the perioperative period has changed during the
course of the pandemic in response to emerging evidence,
but it remains extremely limited in many areas of clinical
concern [3–5]. Non-urgent surgical cases were suspended
for 3 months in the UK in April 2020 due to concern that
NHS capacity might be overwhelmed by patients requiring
respiratory support [6]. Patients requiring urgent and cancer
care were advised surgery would be undertaken but might be
delayed depending on the local infection rate and COVID-19
burden on services. This was set against the potential risk of
harm due to delays in cancer surgery [7].
In response to this developing crisis, we formed a multi-
disciplinary COVID Cancer Surgery group at Nottingham
University Hospitals NHS Trust (NUH) to oversee business
continuity plans and prioritisation of these clinically urgent
and cancer cases. This group not only addressed prioritisation
of cases but also the allocation of constrained resources such
as anaesthetic staffing, post-operative critical care capacity,
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availability of theatre and recovery staff and theatre space
across two NHS hospital sites and two Independent Sector
hospitals in Nottinghamshire. Additional factors for consider-
ation that emerged included availability of appropriate levels
of Personal Protective Equipment (PPE), safety in relation to
aerosol generating procedures (AGPs), access to COVID test-
ing as well as anaesthetic drugs and the need for higher levels
of out of hours medical care in remote sites. Ethical consider-
ations were addressed with input frommembers of the Trust’s
Ethics Committee with inclusion of lay representatives at ev-
ery meeting.
We aim to report the process for forming this committee
alongside the clinical outcomes of planned surgery in
Nottingham during the peak of the pandemic.
Material and methods
Setting
NottinghamUniversity Hospitals (NUH) NHS Trust is a large
teaching hospital which normally serves as a tertiary referral
centre and trauma centre. It is set across 2 campuses with 42
operating theatres and 1300 beds. BMI The Park Hospital and
Spire Nottingham Hospital are Independent Sector sites.
COVID Cancer group
The group was convened by the Deputy Medical Director,
chaired by the Lead Cancer Clinician, and initially consisted
of lead cancer nurses, corporate operations representatives,
senior anaesthetists, critical care consultants and clinical rep-
resentatives of Divisions that undertake cancer surgery in our
Trust. All cancer related and perioperative pathway specialties
were co-opted into the prioritisation group including breast,
colorectal, hepatobiliary, endocrine, gynaecology, head and
neck, neurosurgery, plastics, thoracic, upper gastrointestinal
surgery and urology, with additional support from
microbiology/infectious diseases consultants, administrators
and ethics representatives for the Trust. Each service had al-
ready been asked to identify all patients known to be awaiting
cancer surgery with a documented cancer Multi-disciplinary
team (MDT) outcome and to prioritise them according to clin-
ical need and the availability or otherwise of reasonable alter-
natives to elective surgery. This was soon expanded to clini-
cally urgent cases, including operations or procedures that
might prevent emergency admission as per National guidance.
New cancer (and clinically urgent diagnoses) was prospec-
tively added after appropriate MDT review.
All prioritised cases were submitted to the group and
logged prospectively. All outcomes were audited to ensure
that there was no excess COVID-related morbidity and mor-
tality and that outcomes in the Independent Sector were
comparable to the NHS Trust. The Group passed through a
number of phases in response to the pandemic curve and al-
terations in National and Local guidance. All patients were
consented for their appropriate procedure in line with Trust
standard operating procedure but with the additional risk of
infection with COVID-19 and its associated complications
including an increased risk of mortality.
The group formed a framework for this decision-making
process (Supplementary Figure 1 and Online Resource 1).
Decisions were based around the possibility of delay, or other
treatments, the proposed benefit of surgery with likelihood of
cure, the complexity of the surgery and individualised patient
factors. These decisions were then set in the context of local
COVID-19 infection rates, theatre capacity, critical care ca-
pacity and efficiency considerations.
Phase 1
The first documented inpatient case of SARS-CoV-2 at NUH
was in late February 2020. In the initial phase of the pandemic
when case numbers were low planned surgery continued as
scheduled in line with National guidance. However, in the
second week of March the group was formed and daily meet-
ings were held with core membership as above. The main
drivers for this were: (1) major reconfiguration of anaesthetic
rotas to provide support and cover of the anticipated surge in
Intensive Care Unit (ICU) admissions due to COVID-19, (2)
significant reduction in critical care capacity for elective can-
cer surgery, (3) redeployment of theatre and recover staff usu-
ally available for cancer surgery.
Each specialty was asked to submit their five most urgent
cases daily. The submitted cases were prioritised by the group
and these were mapped to available anaesthetic staff, critical
care capacity and surgical theatre space. Cases were then
booked for the following day accordingly and work was de-
livered by NUH surgeons and anaesthetists in a flexible man-
ner. Cases not allocated were brought back as part of the next
day’s top five cases from each specialty.
Prior to the relatively late introduction of national pre-
screening guidance that changed over the course of the study
interval, elective patients were screened for COVID-19 symp-
toms on the day of surgery by the format of a temperature
check and questionnaire relating to the common symptoms
of SARS-CoV-2 (new continuous cough, loss in sense of
smell or taste and fever During this initial phase, routine pre-
operative PCR swab testing was not widely available. Our
NHS sites developed separate areas and pathways for patients
with suspected or confirmed COVID-19 to minimise risk of
nosocomial spread to other inpatients such as separate emer-
gency resus areas, operating theatres and ICUs [8]. The Park
BMI Hospital and Spire Nottingham Hospital allowed the
development of clean sites for surgery. Clean sites were de-
fined as areas providing care to patients who had been
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previously screened and tested negative by PCR for COVID-
19 infection prior to admission and therefore only accepted
patients who were planned for surgery and did not accept
acute referrals. The Park BMI Hospital comprised 4 operating
theatres, critical care capacity with independent anaesthetic
and critical care staff, as well as independent post-operative
nursing and allied healthcare professional staff pre-operative
assessment. The post-operative sharing of documentation was
rapidly established between the Independent Sector and NHS
Trust allowing integrated patient care through electronic
records.
Phase 2: 26th March–1st of April
Daily meetings continued and the group moved to weekly
allocations. In response to decreased capacity at NUH due to
an increasing COVID burden additional anaesthetic, critical
care, nursing and junior doctor support was provided to the
Independent Sector to start more complex operating. In line
with National guidance pre-operative chest radiographs were
introduced on the day of surgery [3].
Phase 3: 1st April–20th of April
Daily COVID Cancer group meetings continued during this
phase. Pre-operative imaging was removed with patients be-
ing asked to self-isolate for seven days prior to surgery. At the
end of this time period 48-h pre-operative COVID-19 swabs
were introduced in line with National guidance. These swabs
were undertaken in a drive through centre established at the
NHS Trust Genitourinary Medicine site and results were con-
firmed to the patient by text message. Due to the continued
burden on NUH critical care services due to COVID-19 at this
time, most planned surgery was moved to the Independent
Sector. Critical care capacity in the private hospital was fur-
ther increased with an additional seven perioperative care
beds. Approaches from other local Trusts to aid with cancer
surgery capacity were received at this time on an individual
specialty basis and plans put in place to prioritise these pa-
tients through the COVID Surgery group after NUH cancer
MDT review.
Phase 4: 21st April–1st of May
Meetings of the COVID Cancer group reduced to three days a
week. Lists were planned up to 2 weeks in advance to comply
with 7-day isolation periods and latterly moved towards 14
days in accordance with National guidance. All patients were
swabbed 48 h prior to admission for surgery. There was an
increase in critical care capacity at the Independent Sector
therefore allowing increased capacity for more complex cases
to be undertaken. During this time some cases were undertak-
en in NUH because logistical complexity or risks of surgery
precluded use of the private sector, and these factors were felt
to outweigh the risk of COVID-19.
Exposure and outcome definitions
All patients undergoing planned surgery at NUH from 1st
of March until 30th of April 2020 were included in a pro-
spectively collected database (Audit Registration 20-
190C). Any COVID-19 infection was confirmed by a pos-
itive PCR swab from our central laboratory. Suspected
cases included those with positive radiological signs con-
firmed on CT chest or chest radiographs but no confirma-
tory swab. All-cause 30-day mortality was confirmed from
the death date recorded on our electronic record system
along with reporting by each specialty to the group.
COVID-related mortality also included any mortality fol-
lowing a positive COVID swab where the death was
judged to be directly due to COVID within thirty days of
COVID diagnosis. All records were searched for further
deaths via the NHS spine which is updated every 2 weeks
following discharge for patients from out of area. Co-
morbidity was defined from hospital discharge records
using ICD-10 coding and classified using the Charlson
index into 0, 1 or 2 or more co-morbidities [9]. Age at time
of surgery and gender were recorded form the electronic
health records. Length of stay was determined from elec-
tronic hospital admission and discharge records.
COVID-19 infection
To place the surgical outcomes in context, the UK COVID-19
infection rates are presented using routinely collected data
[10]. The numerator being the number of COVID-19 PCR
positive cases recorded by local government area and the
mid-year populations of each local government area were
used to calculate incidence of infection. In addition, all
COVID-19 positive patients identified at the Trust by PCR
were used to show the local inpatient COVID-19 burden dur-
ing the time period by day of diagnosis.
Statistical analysis
Categorical data were summarised using frequencies and per-
centages. Medians are presented with the interquartile range
(IQR). Comparisons were made between categorical data
using Chi Squared or Fisher’s exact tests. All statistics were
performed using Stata 16 SE (StataCorp. 2019. Stata
Statistical Software: Release 16. College Station, TX:
StataCorp LLC). Tests of significance were considered signif-




During the study period, 597 patients underwent a surgical
procedure. Of these 363 (60.8%) were at NUH and 234
(39.2%) in the Independent Sector (Fig. 1) with no fatalities
of oncology and urgent surgical patients on the waiting list. In
total, 162 (27.1%) were day case procedures. The split of
cases by specialty is shown in Table 1. The median age of
patients was 65 years (IQR 54–74 years). In total, 51.8% of
operations were undertaken in males. A cancer diagnosis was
present in 85.9% (513/597) of cases with 87.9% (525/597)
having a Charlson score of one or more. During the time
period, 92 patients had a COVID-19 swab prior to admission
and none were positive.
Patients operated on in the Independent Sector were youn-
ger with a median age of 62 years (IQR 52–73 years) com-
pared to 67 years (IQR 55–74 years) in NUH. The patients in
the Independent Sector were also less likely to have co-
morbidity and were more likely to be females. A greater pro-
portion of thoracic-abdominal procedures were undertaken at
NUH than in the Independent Sector (Table 2). Length of stay




PCR only positive During the time period, 1.3% (8/597) of
patients tested positive for COVID-19 following surgery of
which 50% were male (4/8), 87.5% (7/8) had a cancer
diagnosis or co-morbidity score >1 and all had undergone
surgery at NUH. Five of these patients were diagnosed during
their initial inpatient stay and three tested positive following
discharge. Patients who tested positive for COVID-19 had a
median age of 69.5 years (IQR 58–74.5 years) and length of
stay 13.5 days (IQR 2.5–16 days). Median time from surgery
to diagnosis of COVID-19 infection by PCR test was 6 days
(IQR 4–22.5 days) with five patients presenting symptomati-
cally. Three patients who tested positive by PCR for COVID-
19 infection did not receive a pre-operative PCR swab and
therefore whether these patients were asymptomatic prior to
surgery or developed nosocomial infection is unclear. In pa-
tients having major resections, all of which were abdominal/
thoracic, 3.5% (6/170) developed COVID-19 post-operative-
ly. All these patients were managed on the surgical ward with
no escalation to critical care.
Table 1 Operative procedures by specialty across sites
Specialty NUH (n (%)) Independent Sector (n (%))
Breast 19 (23.5) 62 (76.5)
Colorectal 34 (81.0) 8 (19.0)
Head and neck 44 (77.2) 13 (22.8)
Endocrine 4 (28.6) 10 (71.4)
Gynaecology 35 (87.5) 5 (12.5)
Hepatobiliary 12 (46.2) 14 (53.8)
Neurosurgery 13 (100) 0 (0)
Other 29 (76.3) 9 (23.7)
Plastics 35 (53.0) 31 (47.0)
Urology 72 (50.7) 70 (49.3)
Upper GI 12 (63.2) 7 (36.8)
Thoracics 54 (91.5) 5 (8.5)
Fig. 1 Flow diagram of patients
managed during the period
Langenbecks Arch Surg
COVID-19 suspected on imaging Following surgery 97 had a
post-operative CT scan and 86 had a post-operative chest ra-
diograph. This showed that in addition to the PCR positive
patients, a further ten patients had changes suspected to be
COVID-19 on post-operative imaging. Seven of these cases
were at NUH and three at the Independent Sector site with
none requiring admission to critical care. Six were post-
operatively PCR tested all with a negative COVID-19 result;
the four remaining patients were not PCR tested as this inves-
tigation was not available during their perioperative period.
Overall COVID-19 diagnoses In total, combining those cases
positive on PCR and those with suspected COVID-19 on post-
operative imaging 3.0% (18/597) of patients operated on dur-
ing the period developed confirmed or suspected COVID-19.
In the Independent Sector, 1.3% had a positive swab or
suspected diagnosis compared to 4.1% in the Trust (p=0.047).
COVID-19 related mortality
Thirty-day all-cause mortality overall was 0.7% (4/597) with
one (0.2%) patient dying within 30 days following a COVID-
19 positive diagnosis. The COVID-19 related 30-day mortal-
ity was therefore 12.5% (1/8) of PCR COVID-19 positive
patients and 5.6% (1/18) of radiologically suspected or PCR
confirmed diagnosis of COVID-19. This single death, be-
lieved in part attributable to surgery in combination with
COVID-19 infection, occurred following discharge at another
centre having had a positive post-operative swab for COVID
at NUH.
A second patient who had a positive post-operative
COVID-19 swab died beyond 30 days but shortly after testing
positive for COVID-19. However, this patient was considered
palliative at the time and so although COVID-19 infection
may have contributed to the death, the impact of surgery on
contribution to mortality is debated. The overall mortality to
date beyond 30 days was therefore 25.0% (2/8) for a PCR
positive COVID-19 diagnosis, and 11.1% (2/18) for radiolog-
ically suspected or PCR confirmed diagnoses of COVID-19.
Local infection rates
Figure 2 shows the cumulative number of operative cases
performed per site with the number of cases of PCR positive
COVID-19 infection hospitalised at NUH during the time
period by day. There were no cases of COVID-19 managed
at the clean Independent Sector sites.
Discussion
Following planned urgent and cancer surgery we report an
overall and major resection post-operative COVID-19 infec-
tion rate of 1.3% and 3.5% with no PCR confirmed cases at
our clean site. Overall mortality was low and only two deaths
occurred within 30 days following confirmed or suspected
COVID-19 diagnosis. During the study time period, the inci-
dence of COVID-19 in the East Midlands was 193.7 per
100,000 population and the second lowest by local govern-
ment area in the UK (Fig. 3) [10]. In an area of low incidence
of COVID-19 infection, we have demonstrated that planned
urgent and cancer surgery can be continued in appropriately
counselled patients. This relies on robust systems to prioritise
cases and appropriate resources to undertake surgery. The use
of a clean site does offer additional safety than that achieved
despite precautions in our Trust estate, reflecting the chal-
lenges of segregating patients in an acute Trust with through-
put of non-elective non-isolated inpatients. Access to the
Independent Sector enabled us to establish safe pathways,
with increased transfer of services as the pandemic peaked
to a clean site with no post-operative cases of confirmed
COVID infection.
Patients were identified prospectively and their results
audited in real time to ensure that adverse outcomes were
avoided. It is possible that patients following surgery had
asymptomatic COVID infections so the true rate of infection
may be greater than we report, however all patients with
suspected diagnoses were swabbed or imaged during the
study period. It is possible that patients presented to sites out-
side of the Trust and obtained a diagnosis post discharge. This
study is further limited by its single centre design and potential
extrapolation of results due to the low overall numbers
COVID-19 diagnoses. Therefore, larger multicentred pro-
spective cohorts could provide more robust data although
the feasibility of ensuring multiple institutions conform to
the same prioritisation group standard would pose significant
challenges.
Table 2 Comparison of cases
performed at the Independent
Sector and NUH
NUH Independent Sector p value
Age 67 years (IQR 55–74) 62 years (IQR 52–73) <0.05
Sex F/M 157/206 131/103 <0.05
Co-morbidity >1 89.8% (326/363) 85.0% (199/234) <0.05
Cancer % 89.3% (324/363) 80.8% (189/234) <0.05
Abdomino/thoracic 34.4% (125/363) 19.2% (45/234) <0.05
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Our mortality following a diagnosis of COVID-19 in the
post-operative period is 25% in line with reported studies;
however, this is set against a low infection rate following
surgery [2]. In turn, our low infection rate following surgery
should be contextualised by a low incidence in the surround-
ing area. However, even with this low incidence, local critical
care capacity was exceeded at the peak of the infection curve
requiring more than a doubling of ventilated beds across the
Trust. This would have prevented all operating had the
Independent Sector not been mobilised given the redeploy-
ment of theatre and anaesthetic staff to cover these additional
beds. The formation of the COVID cancer group enabled
cases to be prioritised based on clinical and ethical grounds
and utilise the resources available in the most equitable way.
A similar model of care has been reported in other areas [11].
The current study occurred during the most significant clin-
ical event in the NHS since its inception. It was a constantly
and rapidly evolving situation with new evidence and guid-
ance becoming available on an almost daily basis [3]. Some of
this was based on experience in other health care systems,
particularly China and Italy, where the pandemic had an ear-
lier timeline [12–14]. This resulted in a constantly changing
approach from the surgical and perioperative teams. The
situation continues to evolve and the results presented here
represent only a snapshot of the risks and safety of surgery
within the pandemic environment. Whether this reassurance
remains applicable for future practice is uncertain.
These data should be particularly relevant in the context of
the NHS’s restoration plans [15]. All the cases described herein
involved the treatment of patients with either cancer or other
urgent pathology. The risk of disease progression or even risk to
life in the context of approximately 1% infection risk is likely to
be acceptable to most patients and clinicians. This becomes less
acceptable when the indication for surgery is focused on symp-
tom control or other quality of life indications, and the overall
balance between benefit and risk narrows. Additional surgical
throughput also adds greater strain on prevention measures
such as PPE usage, capacity to test and social distancing. The
last of these also has a potentially significant impact on the bed
availability in NHS Trusts overall. Adherence to pre-operative
self-isolation for 7 days and latterly 14 days has been a key
pillar of our pathway but as the government lifts lockdown,
patients and their families might find this difficult to maintain,
especially in those of working age. Parents and carers of the
paediatric surgical population who have hitherto been unable to
work may find this particularly challenging.
Fig. 2 Daily status of inpatients from day of suspected COVID diagnosis with numbers of operations by setting
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Fig. 3 Map of UK incidence of
COVID by local Government
region by 4th June 2020
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Despite the relatively small sample size the risk of infection
between the clean private sector site and our NUH site appears
substantially different. There are many confounding factors
such as volume, age, co-morbidity, complexity of surgery
and overall length of stay. However, the lack of confirmed
infection within the dedicated clean site, without any non-
elective admissions, remains stark. Our environment within
the Independent Sector during this study would be described
as “E1” by the Association of Coloproctology of Great Britain
and Ireland [16]. By contrast our Trust would be considered
an “E3” environment during this study period. Which compo-
nents of a “clean” environment are of significance is unclear.
It is likely that this might be multi-factorial, with each com-
ponent in combination providingmore than the sum of its part.
This study however is currently the only evidence of the ad-
vantages a true “E1” environment in a UK healthcare setting
and should help direct future plans for restoration of surgical
services. NHS Trusts with estates that allow sites without any
non-elective admissions may be able to reproduce similar out-
comes to our Independent Sector site if local COVID-19 prev-
alence falls, but where this is not possible continued collabo-
ration across all healthcare provides might be necessary.
Equally falling COVID-19 prevalencemay enable similar out-
comes in the acute NHS and may be transferable to regions
outside the NHS globally under similar comparable conditions
but this is by no means guaranteed.
Conclusion
The use of a prioritisation group along with provision of clean
site operating has enabled us to continue to operate on our
urgent and cancer cases during the current pandemic. The
rates of COVID-19 infection following surgery were low but
the mortality associated with this infection was high and pa-
tients need to be consented appropriately for this significant
novel post-operative complication.
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